标题
Ubiquitination of Nonhistone Proteins in Cancer Development and Treatment
作者
关键词
-
出版物
Frontiers in Oncology
Volume 10, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2021-02-13
DOI
10.3389/fonc.2020.621294
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The PROTAC technology in drug development
- (2019) Yutian Zou et al. CELL BIOCHEMISTRY AND FUNCTION
- Developing Targeted Therapies That Exploit Aberrant Histone Ubiquitination in Cancer
- (2019) Lucile Jeusset et al. Cells
- FOXM1 Deubiquitination by USP21 Regulates Cell Cycle Progression and Paclitaxel Sensitivity in Basal-like Breast Cancer
- (2019) Anthony Arceci et al. Cell Reports
- Ubiquitin Ligases in Cancer Immunotherapy – Balancing Antitumor and Autoimmunity
- (2019) Yu Fujita et al. TRENDS IN MOLECULAR MEDICINE
- T Cell Dysfunction in Cancer Immunity and Immunotherapy
- (2019) Anliang Xia et al. Frontiers in Immunology
- Beyond the Cell Surface: Targeting Intracellular Negative Regulators to Enhance T cell Anti-Tumor Activity
- (2019) Sitaram et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- CyclinB1 deubiquitination by USP14 regulates cell cycle progression in breast cancer
- (2019) Bing Liu et al. PATHOLOGY RESEARCH AND PRACTICE
- Selective degradation of BET proteins with dBET1, a proteolysis-targeting chimera, potently reduces pro-inflammatory responses in lipopolysaccharide-activated microglia
- (2018) Kelly M. DeMars et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Cezanne/OTUD7B is a cell cycle‐regulated deubiquitinase that antagonizes the degradation of APC/C substrates
- (2018) Thomas Bonacci et al. EMBO JOURNAL
- MDM2- and FLT3-inhibitors in the treatment of FLT3-ITD acute myeloid leukemia, specificity and efficacy of NVP-HDM201 and midostaurin
- (2018) Katja Seipel et al. HAEMATOLOGICA
- Discovery of QCA570 as an Exceptionally Potent and Efficacious Proteolysis Targeting Chimera (PROTAC) Degrader of the Bromodomain and Extra-Terminal (BET) Proteins Capable of Inducing Complete and Durable Tumor Regression
- (2018) Chong Qin et al. JOURNAL OF MEDICINAL CHEMISTRY
- 3-Fluoro-4-hydroxyprolines: Synthesis, Conformational Analysis, and Stereoselective Recognition by the VHL E3 Ubiquitin Ligase for Targeted Protein Degradation
- (2018) Andrea Testa et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Protein targeting chimeric molecules specific for bromodomain and extra-terminal motif family proteins are active against pre-clinical models of multiple myeloma
- (2018) Xiaohui Zhang et al. LEUKEMIA
- Preclinical evaluation of the selective small-molecule UBA1 inhibitor, TAK-243, in acute myeloid leukemia
- (2018) Samir H. Barghout et al. LEUKEMIA
- Functional TRIM24 degrader via conjugation of ineffectual bromodomain and VHL ligands
- (2018) Lara N. Gechijian et al. Nature Chemical Biology
- A small-molecule inhibitor of the ubiquitin activating enzyme for cancer treatment
- (2018) Marc L Hyer et al. NATURE MEDICINE
- Dual inhibition of MDMX and MDM2 as a therapeutic strategy in leukemia
- (2018) Luis A. Carvajal et al. Science Translational Medicine
- Next-generation proteasome inhibitors for cancer therapy
- (2018) Ji Eun Park et al. Translational Research
- MDM2- and FLT3-inhibitors in the treatment of FLT3-ITD acute myeloid leukemia, specificity and efficacy of NVP-HDM201 and midostaurin
- (2018) Katja Seipel et al. HAEMATOLOGICA
- Human U3 protein14a is a novel type ubiquitin ligase that binds RB and promotes RB degradation depending on a leucine-rich region
- (2018) Huijiao Liu et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Human UTP14a promotes colorectal cancer progression by forming a positive regulation loop with c-Myc
- (2018) Jingyi Zhang et al. CANCER LETTERS
- FBXO38 mediates PD-1 ubiquitination and regulates anti-tumour immunity of T cells
- (2018) Xiangbo Meng et al. NATURE
- A phase I study of SAR405838, a novel human double minute 2 (HDM2) antagonist, in patients with solid tumours
- (2017) Maja de Jonge et al. EUROPEAN JOURNAL OF CANCER
- Deubiquitinating enzyme USP22 positively regulates c-Myc stability and tumorigenic activity in mammalian and breast cancer cells
- (2017) Dongyeon Kim et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Phase I Trial of the Human Double Minute 2 Inhibitor MK-8242 in Patients With Advanced Solid Tumors
- (2017) Andrew J. Wagner et al. JOURNAL OF CLINICAL ONCOLOGY
- BET protein proteolysis targeting chimera (PROTAC) exerts potent lethal activity against mantle cell lymphoma cells
- (2017) B Sun et al. LEUKEMIA
- Phase I/II study of the novel proteasome inhibitor delanzomib (CEP-18770) for relapsed and refractory multiple myeloma
- (2017) Dan T. Vogl et al. LEUKEMIA & LYMPHOMA
- Stability and function of regulatory T cells expressing the transcription factor T-bet
- (2017) Andrew G. Levine et al. NATURE
- Targeted protein degradation by PROTACs
- (2017) Taavi K. Neklesa et al. PHARMACOLOGY & THERAPEUTICS
- Ubiquitin-specific protease 21 stabilizes BRCA2 to control DNA repair and tumor growth
- (2017) Jinping Liu et al. Nature Communications
- USP13 regulates the RAP80-BRCA1 complex dependent DNA damage response
- (2017) Yunhui Li et al. Nature Communications
- The deubiquitinating enzyme USP5 promotes pancreatic cancer via modulating cell cycle regulators
- (2017) Brajesh P. Kaistha et al. Oncotarget
- FBXW7 missense mutation: a novel negative prognostic factor in metastatic colorectal adenocarcinoma
- (2017) Krittiya Korphaisarn et al. Oncotarget
- New strategy for renal fibrosis: Targeting Smad3 proteins for ubiquitination and degradation
- (2016) Xin Wang et al. BIOCHEMICAL PHARMACOLOGY
- The role of deubiquitinases in breast cancer
- (2016) Zhenna Xiao et al. CANCER AND METASTASIS REVIEWS
- Skp2 is over-expressed in breast cancer and promotes breast cancer cell proliferation
- (2016) Wenwen Zhang et al. CELL CYCLE
- Inhibition of bromodomain and extra-terminal (BET) proteins increases NKG2D ligand MICA expression and sensitivity to NK cell-mediated cytotoxicity in multiple myeloma cells: role of cMYC-IRF4-miR-125b interplay
- (2016) Maria Pia Abruzzese et al. Journal of Hematology & Oncology
- A phase I trial of the human double minute 2 inhibitor (MK-8242) in patients with refractory/recurrent acute myelogenous leukemia (AML)
- (2016) Farhad Ravandi et al. LEUKEMIA RESEARCH
- Induced protein degradation: an emerging drug discovery paradigm
- (2016) Ashton C. Lai et al. NATURE REVIEWS DRUG DISCOVERY
- miR-367 promotes the proliferation and invasion of non-small cell lung cancer via targeting FBXW7
- (2016) Jing Xu et al. ONCOLOGY REPORTS
- Usp12 stabilizes the T-cell receptor complex at the cell surface during signaling
- (2016) Akhee S. Jahan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer
- (2016) Kanak Raina et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Selective Small Molecule Induced Degradation of the BET Bromodomain Protein BRD4
- (2015) Michael Zengerle et al. ACS Chemical Biology
- Targeting the ubiquitin pathway for cancer treatment
- (2015) Jia Liu et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4
- (2015) Jing Lu et al. CHEMISTRY & BIOLOGY
- Targeting ubiquitination for cancer therapies
- (2015) John Kenneth Morrow et al. Future Medicinal Chemistry
- E3 Ubiquitin Ligase VHL Regulates Hypoxia-Inducible Factor-1α to Maintain Regulatory T Cell Stability and Suppressive Capacity
- (2015) Jee H. Lee et al. IMMUNITY
- BAP1 regulates cell cycle progression through E2F1 target genes and mediates transcriptional silencing via H2A monoubiquitination in uveal melanoma cells
- (2015) Hui Pan et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Targeting cancer with kinase inhibitors
- (2015) Stefan Gross et al. JOURNAL OF CLINICAL INVESTIGATION
- E3 Ubiquitin Ligase Cbl-b Regulates Thymic-Derived CD4+CD25+Regulatory T Cell Development by Targeting Foxp3 for Ubiquitination
- (2015) Yixia Zhao et al. JOURNAL OF IMMUNOLOGY
- Discovery of a Dihydroisoquinolinone Derivative (NVP-CGM097): A Highly Potent and Selective MDM2 Inhibitor Undergoing Phase 1 Clinical Trials in p53wt Tumors
- (2015) Philipp Holzer et al. JOURNAL OF MEDICINAL CHEMISTRY
- Ubiquitin specific protease 2 acts as a key modulator for the regulation of cell cycle by adiponectin and leptin in cancer cells
- (2015) Saroj Nepal et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDS
- (2015) Jan Krönke et al. NATURE
- Marizomib activity as a single agent in malignant gliomas: ability to cross the blood-brain barrier
- (2015) Kaijun Di et al. NEURO-ONCOLOGY
- The nucleolar ubiquitin-specific protease USP36 deubiquitinates and stabilizes c-Myc
- (2015) Xiao-Xin Sun et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MicroRNA-25 promotes gastric cancer proliferation, invasion, and migration by directly targeting F-box and WD-40 Domain Protein 7, FBXW7
- (2015) Junhua Gong et al. TUMOR BIOLOGY
- Phase I clinical trial of adoptive cellular immunotherapy with APN401 in patients with solid tumors
- (2015) Pierre Triozzi et al. Journal for ImmunoTherapy of Cancer
- Deubiquitination and stabilization of T-bet by USP10
- (2014) Lina Pan et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Discovery of potent and selective spiroindolinone MDM2 inhibitor, RO8994, for cancer therapy
- (2014) Zhuming Zhang et al. BIOORGANIC & MEDICINAL CHEMISTRY
- SAR405838: An Optimized Inhibitor of MDM2-p53 Interaction That Induces Complete and Durable Tumor Regression
- (2014) S. Wang et al. CANCER RESEARCH
- Regulation of c-Myc protein stability by proteasome activator REGγ
- (2014) S Li et al. CELL DEATH AND DIFFERENTIATION
- Bortezomib in multiple myeloma: systematic review and clinical considerations
- (2014) T.C. Kouroukis et al. Current Oncology
- HAUSP, a novel deubiquitinase for Rb - MDM2 the critical regulator
- (2014) Seemana Bhattacharya et al. FEBS Journal
- Regulation of proximal T cell receptor signaling and tolerance induction by deubiquitinase Usp9X
- (2014) Edwina Naik et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Discovery of AMG 232, a Potent, Selective, and Orally Bioavailable MDM2–p53 Inhibitor in Clinical Development
- (2014) Daqing Sun et al. JOURNAL OF MEDICINAL CHEMISTRY
- FBXW7 Mutations in Melanoma and a New Therapeutic Paradigm
- (2014) Iraz T. Aydin et al. JNCI-Journal of the National Cancer Institute
- Synergistic blockade of mitotic exit by two chemical inhibitors of the APC/C
- (2014) Katharine L. Sackton et al. NATURE
- USP37 directly deubiquitinates and stabilizes c-Myc in lung cancer
- (2014) J Pan et al. ONCOGENE
- Ablation of the oncogenic transcription factor ERG by deubiquitinase inhibition in prostate cancer
- (2014) S. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- High throughput screening for inhibitors of the HECT ubiquitin E3 ligase ITCH identifies antidepressant drugs as regulators of autophagy
- (2014) M Rossi et al. Cell Death & Disease
- MYC Degradation
- (2014) A. S. Farrell et al. Cold Spring Harbor Perspectives in Medicine
- Cell Death and Deubiquitinases: Perspectives in Cancer
- (2014) Seemana Bhattacharya et al. Biomed Research International
- Apoptosis and Molecular Targeting Therapy in Cancer
- (2014) Mohamed Hassan et al. Biomed Research International
- Mechanisms of Generating Polyubiquitin Chains of Different Topology
- (2014) Randy Suryadinata et al. Cells
- Versatile Roles of K63-Linked Ubiquitin Chains in Trafficking
- (2014) Zoi Erpapazoglou et al. Cells
- A novel small molecule inhibitor of deubiquitylating enzyme USP14 and UCHL5 induces apoptosis in multiple myeloma and overcomes bortezomib resistance
- (2013) Z. Tian et al. BLOOD
- Arkadia Regulates Tumor Metastasis by Modulation of the TGF- Pathway
- (2013) M. A. Briones-Orta et al. CANCER RESEARCH
- The Ubiquitin Ligase FBXW7 Modulates Leukemia-Initiating Cell Activity by Regulating MYC Stability
- (2013) Bryan King et al. CELL
- Pharmacological Inactivation of Skp2 SCF Ubiquitin Ligase Restricts Cancer Stem Cell Traits and Cancer Progression
- (2013) Chia-Hsin Chan et al. CELL
- Regulation of NF-κB by ubiquitination
- (2013) Jueqi Chen et al. CURRENT OPINION IN IMMUNOLOGY
- The Ubiquitin Ligase Stub1 Negatively Modulates Regulatory T Cell Suppressive Activity by Promoting Degradation of the Transcription Factor Foxp3
- (2013) Zuojia Chen et al. IMMUNITY
- Itch expression by Treg cells controls Th2 inflammatory responses
- (2013) Hyung-seung Jin et al. JOURNAL OF CLINICAL INVESTIGATION
- Discovery of RG7388, a Potent and Selective p53–MDM2 Inhibitor in Clinical Development
- (2013) Qingjie Ding et al. JOURNAL OF MEDICINAL CHEMISTRY
- CDC20 overexpression predicts a poor prognosis for patients with colorectal cancer
- (2013) Wen-jing Wu et al. Journal of Translational Medicine
- Alterations of the Intracellular Peptidome in Response to the Proteasome Inhibitor Bortezomib
- (2013) Julia S. Gelman et al. PLoS One
- Stapled α−helical peptide drug development: A potent dual inhibitor of MDM2 and MDMX for p53-dependent cancer therapy
- (2013) Yong S. Chang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells
- (2013) J. Kronke et al. SCIENCE
- Genomic Instability in Cancer
- (2013) T. Abbas et al. Cold Spring Harbor Perspectives in Biology
- Discovery of RG7112: A Small-Molecule MDM2 Inhibitor in Clinical Development
- (2013) Binh Vu et al. ACS Medicinal Chemistry Letters
- OTUB1 enhances TGFβ signalling by inhibiting the ubiquitylation and degradation of active SMAD2/3
- (2013) Lina Herhaus et al. Nature Communications
- Ubiquitin and Proteasomes in Transcription
- (2012) Fuqiang Geng et al. Annual Review of Biochemistry
- A Small Molecule Inhibitor of Ubiquitin-Specific Protease-7 Induces Apoptosis in Multiple Myeloma Cells and Overcomes Bortezomib Resistance
- (2012) Dharminder Chauhan et al. CANCER CELL
- MYC on the Path to Cancer
- (2012) Chi V. Dang CELL
- MLN4924: a novel first-in-class inhibitor of NEDD8-activating enzyme for cancer therapy
- (2012) Steffan T Nawrocki et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Manadosterols A and B, Sulfonated Sterol Dimers Inhibiting the Ubc13–Uev1A Interaction, Isolated from the Marine Sponge Lissodendryx fibrosa
- (2012) Shuntaro Ushiyama et al. JOURNAL OF NATURAL PRODUCTS
- Triggering Fbw7-Mediated Proteasomal Degradation of c-Myc by Oridonin Induces Cell Growth Inhibition and Apoptosis
- (2012) H.-L. Huang et al. MOLECULAR CANCER THERAPEUTICS
- USP4 is regulated by AKT phosphorylation and directly deubiquitylates TGF-β type I receptor
- (2012) Long Zhang et al. NATURE CELL BIOLOGY
- USP15 stabilizes TGF-β receptor I and promotes oncogenesis through the activation of TGF-β signaling in glioblastoma
- (2012) Pieter J A Eichhorn et al. NATURE MEDICINE
- The ubiquitin ligase CHIP regulates c-Myc stability and transcriptional activity
- (2012) I Paul et al. ONCOGENE
- Tumours associated with BAP1 mutations
- (2012) Rajmohan Murali et al. PATHOLOGY
- Erioflorin Stabilizes the Tumor Suppressor Pdcd4 by Inhibiting Its Interaction with the E3-ligase β-TrCP1
- (2012) Johanna S. Blees et al. PLoS One
- Selective Dual Inhibitors of the Cancer-Related Deubiquitylating Proteases USP7 and USP47
- (2012) Joseph Weinstock et al. ACS Medicinal Chemistry Letters
- USP11 augments TGF signalling by deubiquitylating ALK5
- (2012) M. A. Al-Salihi et al. Open Biology
- The 26S proteasome complex: An attractive target for cancer therapy
- (2011) Sarah Frankland-Searby et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- An Allosteric Inhibitor of the Human Cdc34 Ubiquitin-Conjugating Enzyme
- (2011) Derek F. Ceccarelli et al. CELL
- An Emerging Model for BAP1’s Role in Regulating Cell Cycle Progression
- (2011) Ziad M. Eletr et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Marizomib, a Proteasome Inhibitor for All Seasons: Preclinical Profile and a Framework for Clinical Trials
- (2011) B. C. Potts et al. CURRENT CANCER DRUG TARGETS
- Bortezomib as the First Proteasome Inhibitor Anticancer Drug: Current Status and Future Perspectives
- (2011) D. Chen et al. CURRENT CANCER DRUG TARGETS
- Positive regulation of p53 stability and activity by the deubiquitinating enzyme Otubain 1
- (2011) Xiao-Xin Sun et al. EMBO JOURNAL
- Deubiquitinase USP37 Is Activated by CDK2 to Antagonize APCCDH1 and Promote S Phase Entry
- (2011) XiaoDong Huang et al. MOLECULAR CELL
- Overexpression of Ubiquitin Specific Protease 44 (USP44) Induces Chromosomal Instability and Is Frequently Observed in Human T-Cell Leukemia
- (2011) Ying Zhang et al. PLoS One
- Molecular Mechanisms of Bortezomib Resistant Adenocarcinoma Cells
- (2011) Erika Suzuki et al. PLoS One
- Discovery of Mdm2-MdmX E3 Ligase Inhibitors Using a Cell-Based Ubiquitination Assay
- (2011) A. G. Herman et al. Cancer Discovery
- The potential role of ubiquitin c-terminal hydrolases in oncogenesis
- (2010) Ying Fang et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- A novel orally active proteasome inhibitor ONX 0912 triggers in vitro and in vivo cytotoxicity in multiple myeloma
- (2010) D. Chauhan et al. BLOOD
- Pharmacologic Inhibition of the Anaphase-Promoting Complex Induces A Spindle Checkpoint-Dependent Mitotic Arrest in the Absence of Spindle Damage
- (2010) Xing Zeng et al. CANCER CELL
- Deubiquitinase Inhibition by Small-Molecule WP1130 Triggers Aggresome Formation and Tumor Cell Apoptosis
- (2010) V. Kapuria et al. CANCER RESEARCH
- USP10 Regulates p53 Localization and Stability by Deubiquitinating p53
- (2010) Jian Yuan et al. CELL
- Differential binding of p53 and nutlin to MDM2 and MDMX: Computational studies
- (2010) Thomas Leonard Joseph et al. CELL CYCLE
- Myc protein is stabilized by suppression of a novel E3 ligase complex in cancer cells
- (2010) S. H. Choi et al. GENES & DEVELOPMENT
- The E3 Ubiquitin Ligase GRAIL Regulates T Cell Tolerance and Regulatory T Cell Function by Mediating T Cell Receptor-CD3 Degradation
- (2010) Roza I. Nurieva et al. IMMUNITY
- A Small Ribosomal Subunit (SSU) Processome Component, the Human U3 Protein 14A (hUTP14A) Binds p53 and Promotes p53 Degradation
- (2010) Lelin Hu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Sensitivity to Poly(ADP-ribose) Polymerase (PARP) Inhibition Identifies Ubiquitin-specific Peptidase 11 (USP11) as a Regulator of DNA Double-strand Break Repair
- (2010) Timothy D. Wiltshire et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Enhancement of proteasome activity by a small-molecule inhibitor of USP14
- (2010) Byung-Hoon Lee et al. NATURE
- PARK2 deletions occur frequently in sporadic colorectal cancer and accelerate adenoma development in Apc mutant mice
- (2010) G. Poulogiannis et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Skp2 overexpression increases the expression of MMP-2 and MMP-9 and invasion of lung cancer cells
- (2009) Wen-Chun Hung et al. CANCER LETTERS
- The Deubiquitinating Enzyme BAP1 Regulates Cell Growth via Interaction with HCF-1
- (2009) Yuichi J. Machida et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Small-molecule inhibitor of USP7/HAUSP ubiquitin protease stabilizes and activates p53 in cells
- (2009) F. Colland et al. MOLECULAR CANCER THERAPEUTICS
- An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer
- (2009) Teresa A. Soucy et al. NATURE
- Somatic mutations of the Parkinson's disease–associated gene PARK2 in glioblastoma and other human malignancies
- (2009) Selvaraju Veeriah et al. NATURE GENETICS
- Inactivation of HAUSP in vivo modulates p53 function
- (2009) N Kon et al. ONCOGENE
- A novel small-molecule inhibitor of NF-κB signaling
- (2008) Hiroto Nakajima et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Leucettamol A: A new inhibitor of Ubc13-Uev1A interaction isolated from a marine sponge, Leucetta aff. microrhaphis
- (2008) Sachiko Tsukamoto et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Targeting the p27 E3 ligase SCFSkp2 results in p27- and Skp2-mediated cell-cycle arrest and activation of autophagy
- (2008) Q. Chen et al. BLOOD
- TGFβ in Cancer
- (2008) Joan Massagué CELL
- Dissection of the APCCdh1-Skp2 Cascade in Breast Cancer
- (2008) T. Fujita et al. CLINICAL CANCER RESEARCH
- Targeting tumor cells expressing p53 with a water-soluble inhibitor of Hdm2
- (2008) J. Kitagaki et al. MOLECULAR CANCER THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now